Ribomustin 25 mg and 100 mg Powder for concentrate for solution for infusion.
PDF Leaflet Revision Date: 27 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
First-line treatment of certain leukemias and lymphomas.
Dosage (summary)
IV infusion over 30-60 mins; varies by indication.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- CYP1A2 inhibitors
- Myelosuppressive agents
- Ciclosporin
- Tacrolimus
Contraindications
- Hypersensitivity
- Severe hepatic impairment
- Severe bone marrow suppression
- Pregnancy
- Lactation
Common side effects
- Leukopenia
- Thrombocytopenia
- Nausea
- Vomiting
- Rash
Counselling Points
- Monitor for signs of infection
- Use effective contraception
- Avoid hazardous tasks
- Report severe skin reactions
Serious warnings
- Myelosuppression
- Infections
- Hepatitis B reactivation
- Skin reactions
- Cardiac disorders
Important Disclaimer
The Ribomustin 25 mg and 100 mg Powder for concentrate for solution for infusion. professional information leaflet below is the property of Kiara Health and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
